Close Menu

Proteome Sciences

NEW YORK (GenomeWeb News) – Proteome Sciences today said that revenues for the first half of 2014 were down 12 percent year over year.

NEW YORK (GenomeWeb) – Proteome Sciences said this week that it has signed a $2 million contract with Genting TauRx Diagnostic Centre, an affiliate of TauRx Therapeutics, to provide protein biomarker work in support of the company's Phase III trial of its Alzheimer's drug LMTX.

NEW YORK (GenomeWeb) – Proteome Sciences said today that it has signed a $2 million contract with Genting TauRx Diagnostic Centre, an affiliate of TauRx Therapeutics, to provide protein biomarker work in support of the company's Phase III trial of its Alzheimer's drug LMTX.

NEW YORK (GenomeWeb) – A team led by researchers from King's College London and Proteome Sciences has identified a panel of 10 protein biomarkers that could help predict patients likely to progress from mild cognitive impairment to Alzheimer's disease.

Provista Diagnostics has appointed Rao Mulpuri as chief operating officer.
Mulpuri was previously vice president of laboratory operations for AssureRx Health, and has also held senior positions at Beckman Coulter Genomics and Cogenics.

Proteome Sciences this week posted 2013 revenues of £2.14 million ($3.59 million), up 86 percent from £1.15 million in 2012.

Proteome Sciences has published the first peer-reviewed study of its Sysquant phosphorylation assay, using the product to investigate signaling pathways in pancreatic cancer.

Perthera has hired Subha Madhavan, as its chief data officer. Madhavan will head up the planning and organization of Perthera's data analytic framework, standards, and quality control.

NEW YORK (GenomeWeb News) – Proteome Sciences today announced a conditional placement of nearly 17.9 million new ordinary shares in order to raise £5 million ($8.3 million).

Proteome Sciences said this week that the company has in collaboration with researchers at Kings College Hospital NHS Foundation Trust identified and validated protein biomarkers for patient stratification in liver cancer.

Pages

The former commissioner of the FDA has returned to the venture capital firm New Enterprise Associates as a special partner on the healthcare investment team.

Astronauts have edited yeast genes on the International Space Station in an experiment designed to show how cells repair themselves in space.

Emory University has found that two of its researchers failed to divulge they had received funds from China, according to the Atlanta Journal-Constitution.

In Science this week: influence of the nuclear genome on human mitochondrial DNA, and more.